Cost-Effectiveness of Ticagrelor Compared with Clopidogrel in Patients with Acute Coronary Syndrome from Vietnamese Healthcare Payers ’ Perspective
ConclusionTicagrelor can be considered a cost-effective treatment for ACS compared with clopidogrel from a Vietnamese healthcare payers' perspective.
Source: Advances in Therapy - Category: Drugs & Pharmacology Source Type: research
More News: Cardiology | Cardiovascular | Clopidogrel | Drugs & Pharmacology | Heart | Heart Attack | Plavix | Stroke | Study | Vietnam Health